Company Performance - WORK Medical Technology Group Ltd. experienced a significant price drop of approximately 88% to $0.10, yet remains focused on developing AI-driven medical products through a strategic partnership with the Wuxi Branch of Ruijin Hospital [1][7] - BT Brands, Inc. (BTBDW) saw a 34% decrease in stock price to $0.16, affected by consumer cyclical trends in the quick-service restaurant sector [2][7] - Fitness Champs Holdings Limited (FCHL) faced a 33% decline to $0.71, following its initial public offering where it offered 3.75 million shares at $4.00 each, continuing to contribute to sports education and merchandise sales [3][7] - SAIHEAT Limited (SAIHW) experienced a 32% decline to $0.18, focusing on liquid-cooling data centers and high-performance servers, emphasizing sustainable solutions in the technology sector [4][7] - Zhengye Biotechnology Holding Limited (ZYBT) saw a 28% decrease to $5.01, with a focus on veterinary vaccines and a transformational fiscal year 2024 aimed at diversifying its customer base for long-term growth [5] Industry Dynamics - The market movements reflect the impact of industry dynamics and consumer behavior on company performance, highlighting the need for adaptation to market trends and strategic partnerships for growth [6]

As filed with the U.S. Securities and Exchange Commission on September 18, 2024 Registration No. 333-276436 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 4 TO FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 –––––––––––––––––––– Zhengye Biotechnology Holding Limited (Exact name of registrant as specified in its charter) ____________________ Cayman Islands 2834 Not Applicable (State or other jurisdiction of incorporation or organization) (Primary Standa ...

As filed with the U.S. Securities and Exchange Commission on August 22, 2024 Registration No. 333-276436 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 3 TO FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 –––––––––––––––––––– Zhengye Biotechnology Holding Limited (Exact name of registrant as specified in its charter) ____________________ Cayman Islands 2834 Not Applicable (State or other jurisdiction of incorporation or organization) (Primary Standard ...

AMENDMENT NO. 2 TO FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 –––––––––––––––––––– Zhengye Biotechnology Holding Limited As filed with the U.S. Securities and Exchange Commission on June 14, 2024 Registration No. 333-276436 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Cayman Islands 2834 Not Applicable (State or other jurisdiction of incorporation or organization) (Exact name of registrant as specified in its charter) ____________________ (Primary Standard In ...

As filed with the U.S. Securities and Exchange Commission on May 15, 2024 Registration No. 333-276436 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 –––––––––––––––––––– Zhengye Biotechnology Holding Limited (Exact name of registrant as specified in its charter) ____________________ Cayman Islands 2834 Not Applicable (State or other jurisdiction of incorporation or organization) (Primary Standard Ind ...

As filed with the U.S. Securities and Exchange Commission on January 9, 2024 Registration No. 333-[•] UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ____________________ Zhengye Biotechnology Holding Limited (Exact name of registrant as specified in its charter) ____________________ Cayman Islands 2834 Not Applicable (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classificat ...